
Indride M 2mg/500mg Tablet SR
Marketer
Indmark Biotech Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Indride M 2mg/500mg Tablet SR
Metformin/Sitagliptin 2mg/500mg extended-release tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as advised by your doctor. Lifestyle choices are vital for diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Learn to identify and manage these symptoms. Maintain regular mealtimes and carry a readily available glucose source like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your physician may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Indride M 2mg/500mg Tablet SR
No information provided. Please provide the text you wish to be rewritten.
Uses of Indride M 2mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Indride M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Indride M 2mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
Common Side effects of Indride M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Indride M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Indride M 2mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking. Administer this extended-release tablet with a meal.
How Indride M 2mg/500mg Tablet SR works:
Indride M 2mg/500mg sustained-release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, inhibiting intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Indride M 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Indride M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Indride M tablets (2mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Indride M 2mg/500mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. The use of Indride M 2mg/500mg Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.
LiverCAUTION
Patients with liver impairment should use Indride M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Indride M 2mg/500mg Tablet SR :
Should you forget to take your Indride M 2mg/500mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Indride M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
